222 related articles for article (PubMed ID: 24186132)
1. Bone marrow fibrosis in patients with primary myelodysplastic syndromes has prognostic value using current therapies and new risk stratification systems.
Fu B; Jaso JM; Sargent RL; Goswami M; Verstovsek S; Medeiros LJ; Wang SA
Mod Pathol; 2014 May; 27(5):681-9. PubMed ID: 24186132
[TBL] [Abstract][Full Text] [Related]
2. Impact of the revised International Prognostic Scoring System, cytogenetics and monosomal karyotype on outcome after allogeneic stem cell transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia evolving from myelodysplastic syndromes: a retrospective multicenter study of the European Society of Blood and Marrow Transplantation.
Koenecke C; Göhring G; de Wreede LC; van Biezen A; Scheid C; Volin L; Maertens J; Finke J; Schaap N; Robin M; Passweg J; Cornelissen J; Beelen D; Heuser M; de Witte T; Kröger N;
Haematologica; 2015 Mar; 100(3):400-8. PubMed ID: 25552702
[TBL] [Abstract][Full Text] [Related]
3. Complex or monosomal karyotype and not blast percentage is associated with poor survival in acute myeloid leukemia and myelodysplastic syndrome patients with inv(3)(q21q26.2)/t(3;3)(q21;q26.2): a Bone Marrow Pathology Group study.
Rogers HJ; Vardiman JW; Anastasi J; Raca G; Savage NM; Cherry AM; Arber D; Moore E; Morrissette JJ; Bagg A; Liu YC; Mathew S; Orazi A; Lin P; Wang SA; Bueso-Ramos CE; Foucar K; Hasserjian RP; Tiu RV; Karafa M; Hsi ED
Haematologica; 2014 May; 99(5):821-9. PubMed ID: 24463215
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of blast cell counts in dysplastic bone marrow disorders (MDS and CMML I) with concomitant fibrosis.
Machherndl-Spandl S; Sega W; Bösmüller H; Germing U; Gruber Ch; Nachtkamp K; Reinecke P; Sperr WR; Wimazal F; Müllauer L; Sotlar K; Horny HP; Tüchler H; Valent P; Krieger O
Ann Hematol; 2014 Jan; 93(1):57-64. PubMed ID: 24241126
[TBL] [Abstract][Full Text] [Related]
5. Impact of the International Prognostic Scoring System cytogenetic risk groups on the outcome of patients with primary myelodysplastic syndromes undergoing allogeneic stem cell transplantation from human leukocyte antigen-identical siblings: a retrospective analysis of the European Society for Blood and Marrow Transplantation-Chronic Malignancies Working Party.
Onida F; Brand R; van Biezen A; Schaap M; von dem Borne PA; Maertens J; Beelen DW; Carreras E; Alessandrino EP; Volin L; Kuball JH; Figuera A; Sierra J; Finke J; Kröger N; de Witte T;
Haematologica; 2014 Oct; 99(10):1582-90. PubMed ID: 25085359
[TBL] [Abstract][Full Text] [Related]
6. Myelodysplastic syndromes: 2015 Update on diagnosis, risk-stratification and management.
Garcia-Manero G
Am J Hematol; 2015 Sep; 90(9):831-41. PubMed ID: 26294090
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow fibrosis in myelodysplastic syndromes: a prospective evaluation including mutational analysis.
Ramos F; Robledo C; Izquierdo-García FM; Suárez-Vilela D; Benito R; Fuertes M; Insunza A; Barragán E; Del Rey M; García-Ruiz de Morales JM; Tormo M; Salido E; Zamora L; Pedro C; Sánchez-Del-Real J; Díez-Campelo M; Del Cañizo C; Sanz GF; Hernández-Rivas JM;
Oncotarget; 2016 May; 7(21):30492-503. PubMed ID: 27127180
[TBL] [Abstract][Full Text] [Related]
8. Elevated mature monocytes in bone marrow accompanied with a higher IPSS-R score predicts a poor prognosis in myelodysplastic syndromes.
Wu A; Gao P; Wu N; Shi C; Huang Z; Rong C; Sun Y; Sheng L; Ouyang G; Mu Q
BMC Cancer; 2021 May; 21(1):546. PubMed ID: 33985456
[TBL] [Abstract][Full Text] [Related]
9. Clinical relevance of bone marrow fibrosis and CD34-positive cell clusters in primary myelodysplastic syndromes.
Della Porta MG; Malcovati L; Boveri E; Travaglino E; Pietra D; Pascutto C; Passamonti F; Invernizzi R; Castello A; Magrini U; Lazzarino M; Cazzola M
J Clin Oncol; 2009 Feb; 27(5):754-62. PubMed ID: 19103730
[TBL] [Abstract][Full Text] [Related]
10. The clinical importance of moderate/severe bone marrow fibrosis in patients with therapy-related myelodysplastic syndromes.
Fu B; Ok CY; Goswami M; Xei W; Jaso JM; Muzzafar T; Bueso-Ramos C; Verstovsek S; Garcia-Manero G; Medeiros LJ; Wang SA
Ann Hematol; 2013 Oct; 92(10):1335-43. PubMed ID: 23660629
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow morphology predicts additional chromosomal abnormalities in patients with myelodysplastic syndrome with del(5q).
Geyer JT; Verma S; Mathew S; Wang YL; Racchumi J; Espinal-Witter R; Subramaniyam S; Knowles DM; Orazi A
Hum Pathol; 2013 Mar; 44(3):346-56. PubMed ID: 22995330
[TBL] [Abstract][Full Text] [Related]
12. Allogeneic stem cell transplantation for myelodysplastic syndromes with bone marrow fibrosis.
Kröger N; Zabelina T; van Biezen A; Brand R; Niederwieser D; Martino R; Lim ZY; Onida F; Schmid C; Garderet L; Robin M; van Gelder M; Marks R; Symeonidis A; Kobbe G; de Witte T;
Haematologica; 2011 Feb; 96(2):291-7. PubMed ID: 20971823
[TBL] [Abstract][Full Text] [Related]
13. High flow cytometric scores identify adverse prognostic subgroups within the revised international prognostic scoring system for myelodysplastic syndromes.
Alhan C; Westers TM; Cremers EM; Cali C; Witte BI; Ossenkoppele GJ; van de Loosdrecht AA
Br J Haematol; 2014 Oct; 167(1):100-9. PubMed ID: 24976502
[TBL] [Abstract][Full Text] [Related]
14. Impact of marrow blasts percentage on high-grade myelodysplastic syndrome assessed using revised international prognostic scoring system.
Alkharabsheh O; Patnaik MM; Gangat N; Begna KH; Alkhateeb HB; Shah MV; Hogan WJ; He R; Greipp P; Nguyen PL; Litzow MR; Al-Kali A
Ann Hematol; 2020 Mar; 99(3):513-518. PubMed ID: 31974678
[TBL] [Abstract][Full Text] [Related]
15. Improving Revised International Prognostic Scoring System Pre-Allogeneic Stem Cell Transplantation Does Not Translate Into Better Post-Transplantation Outcomes for Patients with Myelodysplastic Syndromes: A Single-Center Experience.
Alzahrani M; Power M; Abou Mourad Y; Barnett M; Broady R; Forrest D; Gerrie A; Hogge D; Nantel S; Sanford D; Song K; Sutherland H; Toze C; Nevill T; Narayanan S
Biol Blood Marrow Transplant; 2018 Jun; 24(6):1209-1215. PubMed ID: 29474870
[TBL] [Abstract][Full Text] [Related]
16. [Myelodysplastic syndromes. Diagnosis and therapeutic strategies].
Aul C; Giagounidis A; Germing U; Ganser A
Med Klin (Munich); 2002 Nov; 97(11):666-76. PubMed ID: 12434275
[TBL] [Abstract][Full Text] [Related]
17. Additional prognostic impact of the percentage of erythroid cells in the bone marrow of patients with myelodysplastic syndromes.
Neukirchen-Strapatsas J; Tuechler H; Porta MD; Fenaux P; Guerci A; Haas R; Rossi M; Sapena R; Sperr WR; Strupp C; Stamatoullas A; Valent P; Germing U; Bennett JM
Leuk Res; 2019 Feb; 77():8-13. PubMed ID: 30605856
[TBL] [Abstract][Full Text] [Related]
18. Validation of cytogenetic risk groups according to International Prognostic Scoring Systems by peripheral blood CD34+FISH: results from a German diagnostic study in comparison with an international control group.
Braulke F; Platzbecker U; Müller-Thomas C; Götze K; Germing U; Brümmendorf TH; Nolte F; Hofmann WK; Giagounidis AA; Lübbert M; Greenberg PL; Bennett JM; Solé F; Mallo M; Slovak ML; Ohyashiki K; Le Beau MM; Tüchler H; Pfeilstöcker M; Nösslinger T; Hildebrandt B; Shirneshan K; Aul C; Stauder R; Sperr WR; Valent P; Fonatsch C; Trümper L; Haase D; Schanz J
Haematologica; 2015 Feb; 100(2):205-13. PubMed ID: 25344522
[TBL] [Abstract][Full Text] [Related]
19. Revised international prognostic scoring system for myelodysplastic syndromes.
Greenberg PL; Tuechler H; Schanz J; Sanz G; Garcia-Manero G; Solé F; Bennett JM; Bowen D; Fenaux P; Dreyfus F; Kantarjian H; Kuendgen A; Levis A; Malcovati L; Cazzola M; Cermak J; Fonatsch C; Le Beau MM; Slovak ML; Krieger O; Luebbert M; Maciejewski J; Magalhaes SM; Miyazaki Y; Pfeilstöcker M; Sekeres M; Sperr WR; Stauder R; Tauro S; Valent P; Vallespi T; van de Loosdrecht AA; Germing U; Haase D
Blood; 2012 Sep; 120(12):2454-65. PubMed ID: 22740453
[TBL] [Abstract][Full Text] [Related]
20. Prognostic implications of bone marrow culturing in myelodysplastic syndrome: a retrospective analysis.
Raymakers R; Preijers F; Boezeman J; Rutten E; De Witte T
Leuk Lymphoma; 1994 Jun; 14(1-2):111-20. PubMed ID: 7920217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
